These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16808151)

  • 1. Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.
    Park CH; Nguyen SD; Kim MR; Jeong TS; Sok DE
    Lipids; 2006 Apr; 41(4):371-80. PubMed ID: 16808151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position.
    Nguyen SD; Sok DE
    Biochim Biophys Acta; 2006 Apr; 1758(4):499-508. PubMed ID: 16674912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1).
    Nguyen SD; Hung ND; Cheon-Ho P; Ree KM; Dai-Eun S
    Biochim Biophys Acta; 2009 Mar; 1790(3):155-60. PubMed ID: 19103263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
    Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
    Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
    Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
    Sutherland WH; de Jong SA; Walker RJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 activities and genetic variation in childhood obesity.
    Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
    Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
    Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
    Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
    Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
    Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids.
    Nguyen SD; Sok DE
    J Lipid Res; 2004 Dec; 45(12):2211-20. PubMed ID: 15375178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity.
    Gaidukov L; Tawfik DS
    J Lipid Res; 2007 Jul; 48(7):1637-46. PubMed ID: 17435182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity.
    Tavori H; Khatib S; Aviram M; Vaya J
    Bioorg Med Chem; 2008 Aug; 16(15):7504-9. PubMed ID: 18572410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.
    Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J
    Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
    Gaidukov L; Tawfik DS
    Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity.
    Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM
    J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyso-DGTS lipid isolated from microalgae enhances PON1 activities in vitro and in vivo, increases PON1 penetration into macrophages and decreases cellular lipid accumulation.
    Dahli L; Atrahimovich D; Vaya J; Khatib S
    Biofactors; 2018 May; 44(3):299-310. PubMed ID: 29659105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
    Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
    J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.